SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors weigh significant cash holdings and potential acquisition strategies against a lack of immediate operational guidance following the latest earnings release. The community remains deeply polarized, with active debates centered on skepticism toward leadership, frustration over prolonged price stagnation, and persistent hopes for a major catalyst to trigger a move.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining Inc

Cipher Mining is drawing investor focus as it executes a strategic pivot from crypto mining to long-term, hyperscale AI data center infrastructure through multi-year agreements with major cloud providers. The community is closely monitoring the development of these power-intensive facilities and actively discussing the stock's potential for a valuation re-rating as it moves toward fixed-contract revenue models.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the release of an FDA warning letter that flagged promotional claims in company podcasts and advertisements as misleading, a catalyst that triggered significant intraday volatility. The community remains largely bullish, dismissing the letter as standard regulatory friction while actively discussing the potential for a rebound driven by the firm's global expansion and robust underlying clinical data.

🌍 Introduction: A Legendary Icon, Reimagined for the Future The SEAMANIA Protocol, led by SEAMAN Cult, aims to revive one of SEGA Dreamcast's most iconic and best-selling game titles with AI integration—a worldwide cultural phenomenon that won numerous awards in the U.S. and Japan. More than just a game, SEAMAN was the world’s first AI-powered interactive experience, enabling voice-based conversations long before the AI revolution.    Now, SEAMAN returns not as a mere game, but as an advanced AI agent, blending nostalgia with cutting-edge technology. This human-faced fish is reborn as a deeply intelligent, emotionally responsiveAI, offering limitless customization and integration into the modern digital world.  With GenAI-powered customization, users can create their own SEAMAN AI, shaping it into a cherished lostone, a favorite celebrity, or even historical figures. This is no longer a game—it's an AI-driven personal companion and the digital evolution for human interaction.    🔥 Concept: The Wisdom of a Legendary AI-powered Companion At the core of the SEAMANIA Protocol lies the legendary Seaman—a mystical, human-faced fish endowed withancient wisdom and the ability to understand human language. More than just an AI, it is your trustedadvisor, best friend, therapist, personal cheerleader, witty conversationalist, intelligent guide, SEAMANIA is a life coach. Housed in your own digital aquarium, your SEAMAN AI reduces stress, combats loneliness, and guides humanity towards a brighter future. Imagine an AI companion that doesn’t just respond but truly understands, entertains, and supports you—blending humor, sarcasm, and wisdom.

SEAMANIA

SEAMANIA is trending as a highly speculative meme coin, with community members actively coordinating small-increment buying campaigns to trigger rapid price surges. Investors are drawing parallels to other volatile assets while expressing high-stakes optimism about the potential for massive percentage gains despite skepticism regarding its long-term viability.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is surging following a definitive agreement to be acquired by Merck in an all-cash deal valued at approximately $6.7 billion, a move aimed at bolstering Merck's oncology pipeline. Investors are celebrating the substantial premium and the validation of TERN-701's potential in treating chronic myeloid leukemia, while community discussions highlight both the long-awaited payoff for early longs and speculation regarding potential future targets within the biotech sector.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is attracting significant attention as investors position themselves ahead of the upcoming quarterly earnings report, with sentiment divided between concerns over recent stock performance and bullish outlooks driven by the company's strong Autoship subscription model and expansion into veterinary services. Community discourse is heavily focused on whether the stock will finally break its recent downward trend following a potential earnings beat, or if it will face further volatility as traders weigh institutional accumulation against technical support levels.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors grapple with a significant pullback that has left the stock deeply oversold, sparking intense community debate over whether this represents a rare, generational buying opportunity or the beginning of a deeper structural decline. While analysts maintain long-term bullish price targets citing the company's core cloud and AI infrastructure, traders are actively discussing the stock's persistent underperformance relative to broader market indices and the ongoing concerns surrounding AI capital expenditure and competitive pressures.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is currently in the spotlight as investors process a combative rebuttal to a recent short report, with the community actively debating the company's long-term financial health versus the risks of activist short-selling tactics. While some investors remain highly convicted in the firm's fundamental growth trajectory and pending catalysts, the stock's recent volatility has triggered urgent calls for management to provide further clarity and reassure shareholders.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck & Co. has reached a definitive agreement to acquire Terns Pharmaceuticals in a multi-billion-dollar cash deal, signaling a major strategic push to bolster its oncology pipeline ahead of the looming patent expiration for its flagship drug, Keytruda. Investors and community members are actively discussing the premium valuation and the potential for increased competition in the cancer drug market as Merck looks to secure its long-term growth and leadership in the space.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending as investors monitor potential acquisition rumors linked to SpaceX's upcoming IPO and ongoing speculation regarding the strategic value of the company's licensed spectrum. Community discourse is heavily focused on the potential for a bidding war involving major tech giants and the long-term impact of integrating XCOM RAN technology within the broader satellite and 5G infrastructure landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Reports that SpaceX could file its IPO prospectus this week or next boosted proxy-demand positioning.&nbsp;</li><li>Anthropic and OpenAI listing plans are also strengthening momentum.</li><li>VCX’s concentrated exposure to private AI firms makes it one of the few public vehicles offering early positioning ahead of IPO listings.</li></ul>Shares of Fundrise Innovation Fund (VCX) extended their extraordinary rally on Tuesday as investors rushed into one of the few publicly traded vehicles offering exposure to private-market leaders expected to anchor a wave of blockbuster technology listings.&nbsp;<a href="https://stocktwits.com/symbol/VCX">VCX stock</a> soared 64% on Tuesday, pushing its cumulative gains to more than 2,500% since its listing last Thursday.<a href="https://stocktwits.com/symbol/DXYZ">Destiny Tech100 (DXYZ)</a>, another public-market vehicle offering exposure to private AI leader Anthropic, also rose more than 7% in after-hours trading.<h2 class="st-heading-2">SpaceX IPO Filing Timeline Sparks Proxy Demand</h2>Demand for proxy exposure accelerated after recent reports that SpaceX is&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/spacex-ipo-prospectus-near-gary-black-warns-could-pull-investors-from-tesla/cZ3YJCeRI1o">preparing</a> to file its IPO prospectus as soon as this week or next, ahead of a potential June listing expected to become the largest U.S. IPO ever.Advisers involved in the preparation expect the offering to raise more than $75 billion, above earlier estimates of about $50 billion. The company was last valued at around $1.25 trillion following its merger with xAI and could reach roughly $1.75 trillion at listing, placing it among the largest companies in the S&amp;P 500.<h2 class="st-heading-2">Anthropic And OpenAI Add Fuel To The AI IPO Pipeline</h2>Momentum in VCX also reflects positioning ahead of potential listings from major AI firms expected to follow SpaceX into public markets.Anthropic has hired IPO counsel and held preliminary discussions with investment banks ahead of a potential 2026 listing, signaling early-stage preparation for a public-market debut that some investors expect could&nbsp;precede that of rival OpenAI. The company also expanded its Claude assistant’s ability to open applications, navigate browsers, and complete workflow tasks.Meanwhile, OpenAI is said to be laying the groundwork for a potential fourth-quarter listing, holding informal talks with Wall Street banks. On Tuesday, CFO Sarah Friar told&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2026/03/24/openai-secures-an-extra-10-billion-in-record-funding-round-cfo-friar-says.html">CNBC</a> that a new financing round has now expanded to more than $120 billion, potentially its final major private financing ahead of a public-market debut.Together, SpaceX, OpenAI, and Anthropic represent over $2 trillion in combined private-market value and are widely expected to dominate the next phase of large-cap technology listings.<h2 class="st-heading-2">VCX Portfolio Offers Direct AI IPO Exposure</h2>The newly listed closed-end fund has surged more than 1,500% above its net asset value since debuting last week, with shares trading at more than 16x its latest NAV of $18.97, highlighting strong demand for early positioning ahead of IPOs by SpaceX, Anthropic and OpenAI.Most VCX shares acquired before Feb.20 remain subject to a six-month lockup following the listing, leaving only a relatively small portion of shares available for trading.AI accounts for about 44% of&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/public-fund-retail-access-spacex-openai-anthropic-backs-palmer-luckey-bank/cZ3nEEURIKX">VCX’s portfolio</a> and data infrastructure 22.9%, with the remainder spread across fintech, aerospace, gaming, software, healthcare, proptech and about 13.6% held in cash and fixed income. Anthropic is the fund’s largest position at roughly 20.7%, followed by Databricks at 17.7%, OpenAI at 9.9%, Anduril at 6.9%, Ramp at 5.1% and SpaceX at 5%.Since Anthropic is the fund’s single largest holding, investors have already begun estimating what a future public listing could imply for VCX’s portfolio value.CVX’s portfolio returned about 21% over the past three months, 13% year to date and 63% over the past 12 months. Since its July 2022 inception, cumulative returns total roughly 84%, meaning a $10,000 investment would have grown to about $19,256, including $9,030 in appreciation and $225 in distributions, according to Fundrise data.<h2 class="st-heading-2">Blockbuster Listings May Pull Capital From Smaller IPOs</h2>If SpaceX, OpenAI and Anthropic list at valuations roughly 20% above their latest funding rounds, their combined public-market debut could add more than $3 trillion to U.S. equity market capitalization, Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/features/2026-03-11/spacex-openai-potential-ipos-spur-murky-deals-to-buy-stock">noted</a>.Vineet Jain, founder of Egnyte, said the companies could “vacuum a lot of liquidity out of the market,” reflecting concerns that capital could shift away from smaller IPO candidates and toward a handful of dominant listings, according to a Barron’s&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.barrons.com/articles/anthropic-openai-spacex-value-ai-ipo-39d1e556">report</a>.Large passive funds, benchmark allocators and growth-focused portfolios typically reposition ahead of listings of huge scale, which helps explain why investors are seeking exposure through proxy vehicles before IPO pricing is finalized.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for VCX was ‘extremely bullish’ amid over a 6,000% surge in message volumes over the past week.<figure class="image"><img src="https://news.stocktwits-cdn.com/vcx_ss_png_7fb7cf4c41.webp" alt="vcx ss.png" width="964" height="145"><figcaption>VCX sentiment and message volume as of March 25 | Source: Stocktwits</figcaption></figure>One user called VCX&nbsp;“one of those wild ones” and&nbsp;<a href="https://stocktwits.com/Bennetthall/message/648466546">noted</a> that it had surged rapidly from $120 earlier in the week to levels comparable with large-cap names such as Micron, Home Depot, or Sandisk. “The book value doesn’t add up on this. I’m wondering who else is analyzing that when you add up the value of everything they own this is inflated by about 5X but apparently retail doesn’t care.”<stembedurl>https://stocktwits.com/Bennetthall/message/648466546</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/Ma_Power71/message/648468879">expects</a> VCX to “issue new shares after lock-up period ends for this to drop only 700 mil NaV.”<stembedurl>https://stocktwits.com/Ma_Power71/message/648468879</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

VCX stock soared 64% on Tuesday, pushing its cumulative gains to more than 2,500% since its listing last Thursday. (Photo credot: Getty Images)

VCX Stock On Red-Hot Streak: Retail Traders Scramble For SpaceX, Anthropic And OpenAI Exposure Ahead Of Mega IPO Wave

VCX traded over 16x its net asset value, signaling strong investor demand for pre-IPO exposure.

VCX Emerges As Hottest Proxy Trade For Investors Craving Exposure To SpaceX, OpenAI, Anthropic 

Equity

Destiny Tech100 (NYSE:DXYZ)  Shares Down 3%   - Time to Sell?

Destiny Tech100 (NYSE:DXYZ) Trading Down 3% - Time to Sell...

Destiny Tech100 (NYSE:DXYZ) Trading 1.9% Higher - Here's Why

Destiny Tech100 (NYSE:DXYZ) Shares Up 1.9% - Here's What Happened...

Destiny Tech100 Inc. (NYSE:DXYZ) Sees Large Growth in Short Interest

Destiny Tech100 Inc. (NYSE:DXYZ - Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 13th, there was short interest totaling...

Destiny Tech100 (NYSE:DXYZ) Shares Up 3.1% - What's Next?

Destiny Tech100 (NYSE:DXYZ) Shares Up 3.1% - What's Next...

Destiny Tech100 (NYSE:DXYZ) Shares Down 3.7% - Here's What Happened

Destiny Tech100 (NYSE:DXYZ) Shares Down 3.7% - Here's Why...

Destiny Tech100 (NYSE:DXYZ) Stock Price Down 2% - Here's Why

Destiny Tech100 (NYSE:DXYZ) Trading Down 2% - What's Next...

Destiny Tech100 (NYSE:DXYZ) Shares Down 2.2% - What's Next?

Destiny Tech100 (NYSE:DXYZ) Trading Down 2.2% - Here's Why...

Destiny Tech100 (NYSE:DXYZ) Trading Down 2.2% - Should You Sell?

Destiny Tech100 (NYSE:DXYZ) Trading Down 2.2% - Should You Sell...

Destiny Tech100 (NYSE:DXYZ) Shares Down 1% - Here's What Happened

Destiny Tech100 (NYSE:DXYZ) Shares Down 1% - Here's Why...

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

iShares Dynamic Equity Active ETF ($BDYN)

Grayscale Bitcoin Trust ETF ($GBTC)

Destiny Tech100 Inc ($DXYZ)

Global X Defense Tech ETF ($SHLD)

The Modern Portfolio Builder. This award honors the fund that makes long-term investing easier, cheaper, or more effective for people who want to "set it and forget it."

Stocktwits

Stocktwits Polls

DESTINY TECH 100 INC

Rumors of an imminent IPO filing for SpaceX are driving significant retail interest and price speculation.

Traders are actively comparing premiums to Net Asset Value across space and AI-focused investment vehicles.

Investors are weighing the portfolios of high-profile private equity holdings like Anthropic, OpenAI, and SpaceX.

The thin float and short interest metrics are fueling debates about potential squeezes and long-term sustainability.

Destiny Tech 100 is drawing significant investor attention as rumors of a potential SpaceX IPO intensify, with traders debating whether to buy the stock as a proxy for SpaceX and Anthropic exposure or to avoid it due to its high trading premium relative to net asset value. Community sentiment remains polarized, as bulls focus on the fund's high-profile private tech holdings, while bears emphasize its premium-to-NAV disconnect and the risks associated with holding a closed-end fund.

Current Price	$26.52
Prev Close	$24.27
Open	$24.80
Dividend Yield	0.00%
50-Day Moving Average	$28.87
Beta	2.90
Avg. Volume	1.01M
PE Ratio	7.49

52-Week High	$50.50
52-Week Low	$19.71
Market Capitalization	$382.63M
EPS (Annual)	$3.54
Price to Book	1.33
Revenue Per Employee	N/A

DXYZ
DESTINY TECH 100 INC

Feed

News

Sentiment

Fundamentals

Info

Latest DXYZ News

DXYZDESTINY TECH 100 INC